SOGA Lasers therapy system family of Aurora handpiece (Aurora-S); SOGA Lasers therapy system family of the Dental diode laser ( ILaser III Pro)
Shenzhen Soga Technology Co., Ltd. · Decision date May 19, 2026
What did the FDA decide?
FDA records K253309 as a 510(k) premarket notification, with a decision dated May 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- May 19, 2026
Regulatory record facts
- Identifier
- K253309
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Shenzhen Soga Technology Co., Ltd.
- Product code
- NVK
- Decision code
- SESE
- Decision date
- May 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Laser, Dental, Soft Tissue.
- Applicant
- Shenzhen Soga Technology Co., Ltd.
- Product code
- NVK
- FDA device class
- 2
FDA decision timeline
K253309 received
Application receipt date recorded by FDA.
K253309 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NVK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Azena Medical, LLC | 510(k) clearance | Mar 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Soga Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K253309
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records